Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial

Kristine Ensrud, Andrea Lacroix, John R. Thompson, David D. Thompson, Richard Eastell, David M. Reid, Slobodan Vukicevic, Jane Cauley, Elizabeth Barrett-Connor, Roisin Armstrong, Francine Welty, Steven Cummings

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences